Discover 503 paid clinical trials in Louisville, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 503
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Louisville KY, Nashville TN, Ann Arbor MI, Zion IL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase 3, Recruiting
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
for
Small-cell Lung Cancer
Location: Louisville KY, Nashville TN, Sarasota FL, St Louis MO,
Sponsor: Zai Lab (Shanghai) Co., Ltd.
Sex: All
Age: 18+
Code: NCT07218146
Phase 3, Recruiting
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
for
Extensive Stage Small Cell Lung Cancer
Location: Louisville KY, St Louis MO, Memphis TN, Atlanta GA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037758
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
for
Small Cell Lung Cancer (SCLC),
Location: Louisville KY, Memphis TN, Atlanta GA, Pittsburgh PA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07472517
Phase 3, Recruiting
A Study of ZW251 in Participants With Advanced Solid Tumors
for
Hepatocellular Carcinoma,
Location: Louisville KY, Grand Rapids MI, Hackensack NJ,
Sponsor: Zymeworks BC Inc.
Sex: All
Age: 18+
Code: NCT07164313
Phase 1, Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
for
Myelodysplastic Syndrome, Anemia
Location: Louisville KY, Nashville TN, Skokie IL, Wheeling WV,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT07422480
Phase 3, Recruiting
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
for
Lymphoid Malignancies
Location: Louisville KY, Chicago IL, Canton OH, Memphis TN,
Sponsor: AVM Biotechnology Inc
Sex: All
Age: 12 - 70+
Code: NCT04329728
Phase 1, Phase 2, Recruiting
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
for
Gastric or Gastroesophageal Junction Adenocarcinoma,
Location: Louisville KY, Pittsburgh PA, Madison WI, Iowa City IA,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05482893
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors, Colorectal Cancer
Location: Louisville KY, Nashville TN, Ann Arbor MI, Atlanta GA,
Sponsor: Vividion Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06004245
Phase 1, Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Hematological Malignancies
Location: Louisville KY, St Louis MO, Ann Arbor MI, Atlanta GA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT04634552
Phase 2, Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells